Skip to main content
Caplight Logo









Simplicia, Inc.

Simplicia, Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://simplicia.bio/

Last Round

Seed

Aug 13, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Simplicia, Inc. is a biotechnology company that provides an AI-native drug discovery platform for identifying therapeutic candidates from historical medical evidence.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

drug discoveryAI drug discoverynatural product discoveryethnobotanypharmacopoeianew chemical entitiesNCE505(b)(2) pathwaybiotech AIin silico drug discoverycomputational biologytherapeutic candidate identificationAI-native platformpharma R&Ddrug development software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Simplicia, Inc. Comparables

Compare Simplicia, Inc. with similar companies based on industry and business-model similarity.

Simplicia, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Montai Health
82%
Pangea Bio
82%
Novogaia
78%

Simplicia, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 13, 2026

Key People

Founding team and executive leadership

Katherine Arline

Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 13, 2026

    $600K Seed Round raised.

Simplicia, Inc. Filings

Explore SEC and related filing metadata, where available.

Simplicia, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Simplicia, Inc.'s valuation, stock price, and market status.

Is Simplicia, Inc. a public or private company?

Simplicia, Inc. is a private company.

What is the current stock price of Simplicia, Inc.?

Simplicia, Inc. is a private company with no public stock price. Caplight tracks Simplicia, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Simplicia, Inc. worth (valuation)?

Valuation information for Simplicia, Inc. is not publicly available.

Can I buy Simplicia, Inc. stock?

Simplicia, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Simplicia, Inc.'s last funding round?

Simplicia, Inc.'s most recent funding round was Seed Round on August 13, 2026.

Who are the main investors in Simplicia, Inc.?

Investor information for Simplicia, Inc. is not publicly disclosed.

Will Simplicia, Inc. IPO soon?

No public IPO plans have been announced for Simplicia, Inc..

How can I track Simplicia, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Simplicia, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range1
Year Founded2026
Last FundingAug 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?